UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$456M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$403M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$391M |
| 4 |
iShares MSCI ACWI ETF
ACWI
|
+$381M |
| 5 |
UnitedHealth
UNH
|
+$355M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$3.79B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$626M |
| 3 |
Microsoft
MSFT
|
+$596M |
| 4 |
Johnson & Johnson
JNJ
|
+$307M |
| 5 |
iShares TIPS Bond ETF
TIP
|
+$256M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.25% |
| 2 | Financials | 6.72% |
| 3 | Healthcare | 6.58% |
| 4 | Consumer Discretionary | 5.35% |
| 5 | Industrials | 4.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5351
Goldman Sachs Access Inflation Protected USD Bond ETF
GTIP
$295M
| $244K | ﹤0.01% |
4,971
+4,841
| +3,724% | +$240K |
|
5352
Invesco Active US Real Estate Fund
PSR
$60M
| $244K | ﹤0.01% |
2,811
-691
| -20% | -$58.8K |
|
5353
Relmada Therapeutics
RLMD
$527M
| $244K | ﹤0.01% |
98,988
+97,410
| +6,173% | +$269K |
|
|
IMGN
5354
PUT
DELISTED
Immunogen Inc
IMGN
| $243K | ﹤0.01% |
+12,900
| New | +$152K |
|
5355
Nuveen Minnesota Quality Municipal Income Fund
NMS
$74.2M
| $243K | ﹤0.01% |
21,724
-4,449
| -17% | -$50.6K |
|
5356
Daily Journal
DJCO
$778M
| $242K | ﹤0.01% |
838
+389
| +87% | +$110K |
|
5357
Plumas Bancorp
PLBC
$429M
| $242K | ﹤0.01% |
6,787
+3,040
| +81% | +$108K |
|
|
CEV
5358
Eaton Vance California Municipal Income Trust
CEV
$73.6M
| $241K | ﹤0.01% |
24,168
-612
| -2% | -$6.14K |
|
5359
Phathom Pharmaceuticals
PHAT
$692M
| $241K | ﹤0.01% |
+16,806
| New | +$194K |
|
5360
Build-A-Bear
BBW
$462M
| $241K | ﹤0.01% |
11,235
+3,460
| +45% | +$75.7K |
|
5361
Descartes Systems
DSGX
$6.82B
| $241K | ﹤0.01% |
3,003
+32
| +1% | +$2.49K |
|
5362
CNB Financial Corp
CCNE
$1.03B
| $240K | ﹤0.01% |
13,577
+6,953
| +105% | +$124K |
|
5363
ProShares MSCI EAFE Dividend Growers ETF
EFAD
$64.5M
| $239K | ﹤0.01% |
6,449
+3,351
| +108% | +$127K |
|
5364
Viemed Healthcare
VMD
$371M
| $238K | ﹤0.01% |
24,354
+20,063
| +468% | +$204K |
|
5365
Silvercrest Asset Management
SAMG
$79.9M
| $238K | ﹤0.01% |
11,742
+2,577
| +28% | +$49.3K |
|
5366
Castle Biosciences
CSTL
$979M
| $237K | ﹤0.01% |
17,305
+6,731
| +64% | +$136K |
|
5367
Farmers & Merchants Bancorp
FMAO
$481M
| $237K | ﹤0.01% |
10,543
+2,812
| +36% | +$61.8K |
|
5368
United-Guardian
UG
$33.5M
| $237K | ﹤0.01% |
28,657
+2,823
| +11% | +$25.9K |
|
5369
BOK Financial
BOKF
$8.74B
| $237K | ﹤0.01% |
2,928
-8,372
| -74% | -$690K |
|
5370
Invesco S&P SmallCap Consumer Staples ETF
PSCC
$39.1M
| $236K | ﹤0.01% |
6,510
-177
| -3% | -$6.45K |
|
5371
Invesco CurrencyShares Swiss Franc Trust
FXF
$398M
| $236K | ﹤0.01% |
2,373
+29
| +1% | +$2.88K |
|
5372
Southern Missouri Bancorp
SMBC
$850M
| $235K | ﹤0.01% |
6,109
+2,809
| +85% | +$103K |
|
|
PNNT
5373
Pennant Park Investment Corp
PNNT
$241M
| $234K | ﹤0.01% |
39,696
+4,162
| +12% | +$22.5K |
|
5374
Midland States Bancorp
MSBI
$695M
| $233K | ﹤0.01% |
11,727
-5,776
| -33% | -$117K |
|
5375
Oil-Dri
ODC
$1.34B
| $233K | ﹤0.01% |
7,898
+3,136
| +66% | +$69.4K |
|
Similar funds
UBS Group's Q2 2023 Portfolio in Review
As of Q2 2023, UBS Group held 10,482 positions worth $296B, up 8.2% from $274B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS Group's Q2 2023 filing shows 945 new, 3,995 increased, 3,455 reduced and 1,657 closed positions. Its largest new stake was Global X Emerging Markets Great Consumer ETF: 1,048,148 shares worth $26.1M. The largest sale was UBS Group, an estimated $3.79B.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q2 2023 buy was Global X Emerging Markets Great Consumer ETF: 1,048,148 shares worth $26.1M.
- UBS Group added most to State Street Financial Select Sector SPDR ETF in Q2 2023, an estimated $456M increase.
- UBS Group's biggest Q2 2023 reduction was UBS Group, cutting an estimated $3.79B.
- UBS Group fully exited DCP Midstream, LP in Q2 2023, selling an estimated $148M.
- UBS Group's ten largest holdings make up 14% of its $296B portfolio in Q2 2023.
- UBS Group opened 945 new positions and closed 1,657 in Q2 2023.
- UBS Group's portfolio value rose 8.2% quarter-over-quarter to $296B.
Based on UBS Group's 13F filing for Q2 2023, filed 11 Aug 2023.